SCHEMBL13085576

SCHEMBL13085576

CCOC(=O)[C@@H](Cc1cccc(OC[C@@H]2CO2)c1)OC(C)C

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.48
ALDH1A1 P00352 3/20 0.48
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HIF1A Q16665 1/20 0.48
MAPK1 P28482 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
GRM2 Q14416 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
FFAR1 O14842 3/20 0.37
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
ACACB O00763 1/20 0.37
ACACA Q13085 1/20 0.37
GLA P06280 1/20 0.35
MGLL Q99685 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13819365 1.00 TSHR (0.48) TSHRALDH1A1TP53CYP3A4SMN1; SMN2
SCHEMBL13810494 1.00 TSHR (0.48) TSHRALDH1A1TP53CYP3A4SMN1; SMN2
SCHEMBL13810477 1.00 TSHR (0.48) TSHRALDH1A1TP53CYP3A4SMN1; SMN2
SCHEMBL4558827 1.00 TSHR (0.48) TSHRALDH1A1TP53CYP3A4SMN1; SMN2
SCHEMBL2866318 0.88 ALDH1A1 (0.51) TSHRALDH1A1TP53CYP3A4SMN1; SMN2
SCHEMBL4558998 0.87 PPARG (0.42) TSHRALDH1A1TP53HIF1ATDP1
SCHEMBL14309181 0.84 TSHR (0.52) TSHRALDH1A1TP53CYP3A4SMN1; SMN2
SCHEMBL13091916 0.81 ALDH1A1 (0.59) TSHRALDH1A1TP53CYP3A4SMN1; SMN2
SCHEMBL13810945 0.79 L3MBTL1 (0.44) TSHRALDH1A1TP53MAPK1L3MBTL1
SCHEMBL4339926 0.79 MAPK1 (0.46) TSHRALDH1A1MAPK1L3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816405-B2 Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-10-19 US disclosed
US-20070117866-A1 Calcium bis [ (2S) - 3- [3-[ (2S) -3- (4-chloro-2-cyanophenoxy) -2- fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof EISAI CO., LTD. (JP) 2007-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070117866-A1 Calcium bis [ (2S) - 3- [3-[ (2S) -3- (4-chloro-2-cyanophenoxy) -2- fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof CA2, CACNA1A, CACNA1C TSHR 4017/4885ALDH1A1 1347/4885TP53 3083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.